1. NF-κB Metabolic Enzyme/Protease Immunology/Inflammation
  2. NF-κB Heme Oxygenase (HO) Interleukin Related Reactive Oxygen Species (ROS) NO Synthase
  3. Nrf2 activator-24

Nrf2 activator-24 is a Nrf2 activator with anti-inflammatory and antioxidant activities. Nrf2 activator-24 promotes the nuclear translocation of Nrf2, thereby inducing the expression of downstream antioxidant and cytoprotective genes. Nrf2 activator-24 inhibits cytokine-driven inflammatory responses in keratinocytes. Nrf2 activator-24 attenuates inflammation, nitrosation and oxidative stress responses in macrophages. Nrf2 activator-24 alleviates local inflammation and atopic dermatitis-like symptoms in DNCB-induced mouse models. Nrf2 activator-24 can be used in research related to atopic dermatitis.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

Nrf2 activator-24

Nrf2 activator-24 構造式

容量 在庫状況
50 mg   お問い合わせ  
100 mg   お問い合わせ  
250 mg   お問い合わせ  

* アイテムを追加する前、数量をご選択ください

This product is a controlled substance and not for sale in your territory.

Top Publications Citing Use of Products

NF-κB アイソフォーム固有の製品をすべて表示:

Heme Oxygenase (HO) アイソフォーム固有の製品をすべて表示:

Interleukin Related アイソフォーム固有の製品をすべて表示:

NO Synthase アイソフォーム固有の製品をすべて表示:

  • 生物活性

  • 純度とドキュメンテーション

  • 参考文献

  • カスタマーレビュー

製品説明

Nrf2 activator-24 is a Nrf2 activator with anti-inflammatory and antioxidant activities. Nrf2 activator-24 promotes the nuclear translocation of Nrf2, thereby inducing the expression of downstream antioxidant and cytoprotective genes. Nrf2 activator-24 inhibits cytokine-driven inflammatory responses in keratinocytes. Nrf2 activator-24 attenuates inflammation, nitrosation and oxidative stress responses in macrophages. Nrf2 activator-24 alleviates local inflammation and atopic dermatitis-like symptoms in DNCB-induced mouse models. Nrf2 activator-24 can be used in research related to atopic dermatitis[1].

体外実験

Nrf2 activator-24 (various concentrations; 6 h) potently induces Nrf2 nuclear translocation in engineered U2OS cells with an EC50 of 4.9 ± 0.3 nM[1].
Nrf2 activator-24 (up to 1 μM; 24 h) is non-cytotoxic to HaCaT human keratinocytes[1].
Nrf2 activator-24 (0.1 μM; up to 24 h) induces peak Nrf2 nuclear translocation in HaCaT human keratinocytes at 3 h post-treatment, with levels decreasing thereafter up to 24 h[1].
Nrf2 activator-24 (increasing concentrations; 6 h (Nrf2), 12 h (HO-1, GCLM)) induces concentration-dependent increases in Nrf2, HO-1, and GCLM protein expression in HaCaT human keratinocytes, with maximal effects at 1 μM[1].
Nrf2 activator-24 (increasing concentrations; 6 h) induces concentration-dependent increases in HMOX1, GCLM, GCLC, and NQO1 mRNA expression in HaCaT human keratinocytes, with maximal effects at 1 μM[1].
Nrf2 activator-24 (0.03-1 μM; 3 h pretreatment, 24 h cytokine stimulation) concentration-dependently suppresses IL-1β protein expression in TNF-α+IFN-γ-stimulated HaCaT human keratinocytes[1].
Nrf2 activator-24 (0.03-1 μM; 6 h pretreatment, 3 h cytokine stimulation (IL6, TNF); 24 h cotreatment (CCL17, CCL22)) concentration-dependently suppresses IL6, TNF, CCL17, and CCL22 mRNA expression in TNF-α+IFN-γ-stimulated HaCaT human keratinocytes[1].
Nrf2 activator-24 (0.03-1 μM; 3 h pretreatment, 24 h LPS stimulation) concentration-dependently suppresses iNOS protein expression in LPS-stimulated Raw264.7 mouse macrophages[1].
Nrf2 activator-24 (0.03-1 μM; 3 h pretreatment, 24 h LPS stimulation) concentration-dependently suppresses NO production in LPS-stimulated Raw264.7 mouse macrophages[1].
Nrf2 activator-24 (0.1 μM; 9 h pretreatment) effectively reduces H2O2-induced intracellular ROS levels in Raw264.7 mouse macrophages[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Cytotoxicity Assay[1]

Cell Line: HaCaT human keratinocytes
Concentration: up to 1 μM
Incubation Time: 24 h
Result: Showed no cytotoxic effects on HaCaT keratinocytes at concentrations up to 1 μM.

Western Blot Analysis[1]

Cell Line: HaCaT human keratinocytes
Concentration: 0.003, 0.01, 0.03, 0.1 μM
Incubation Time: 3 h
Result: Increased nuclear Nrf2 in a concentration-dependent manner.
Induced a significant 3.60 ± 0.11-fold increase in nuclear Nrf2 at 0.003 μM.

Western Blot Analysis[1]

Cell Line: HaCaT human keratinocytes
Concentration: 0.03, 0.1, 0.3, 1 μM
Incubation Time: 6 h (Nrf2); 12 h (HO-1, GCLM)
Result: Increased Nrf2 protein accumulation to 5.71 ± 0.10-fold at 1 μM (6 h treatment).
Upregulated HO-1 and GCLM expression by 10.58 ± 0.74-fold and 3.44 ± 0.11-fold, respectively, at 1 μM (12 h treatment).

Western Blot Analysis[1]

Cell Line: TNF-α+IFN-γ-stimulated HaCaT human keratinocytes
Concentration: 0.03, 0.1, 0.3, 1 μM
Incubation Time: 3 h pretreatment; 24 h cytokine stimulation
Result: Suppressed TNF-α+IFN-γ-induced IL-1β protein expression in a concentration-dependent manner.

Western Blot Analysis[1]

Cell Line: LPS-stimulated Raw264.7 mouse macrophages
Concentration: 0.03, 0.1, 0.3, 1 μM
Incubation Time: 3 h pretreatment; 24 h LPS stimulation
Result: Suppressed LPS-induced iNOS protein expression in a concentration-dependent manner.
体内実験

Nrf2 activator-24 (0.1-0.5%; topical administration; once every 2 days; days 8-14) effectively alleviates DNCB-induced atopic dermatitis-like symptoms in BALB/c mice[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: BALB/c (6-week-old male, DNCB-induced atopic dermatitis model)[1]
Dosage: 0.1%; 0.5%
Administration: topical; every other day; Days 8-14, 1 hour after DNCB challenge
Result: Significantly reduced dermatitis scores.
Significantly suppressed scratching behavior.
Reduced spleen and lymph node weights in a concentration-dependent manner.
Significantly lowered plasma IgE levels.
Significantly attenuated epidermal thickening.
Significantly reduced eosinophil infiltration in dorsal skin.
Significantly reduced mast cell infiltration in dorsal skin (0.5% group); showed near-significant reduction (0.1% group).
Significantly reduced skin IL-6 protein levels in a concentration-dependent manner.
Significantly restored skin loricrin protein levels.
分子量

360.09

分子式

C14H10Cl2O2Se

SMILES

ClC1=C([Se](/C=C/C2=CC=CC=C2Cl)(=O)=O)C=CC=C1

輸送条件

Room temperature in continental US; may vary elsewhere.

保管条件

Please store the product under the recommended conditions in the Certificate of Analysis.

純度とドキュメンテーション
参考文献
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

質量   濃度   体積   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

一般には略語で表示されます:C1V1 = C2V2

濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

最近チェックした製品:

オンラインお問い合わせ

Your information is safe with us. * Required Fields.

製品名

 

カスタマ需要量 *

お名前 *

 

タイトル

メールアドレス *

 

電話番号 *

デパートメント

 

組纖名 *

市区町村

都道府県

国或いは地域 *

     

必ず会社名を記載ください。個人への返信は行いません。

備考

バルクお問い合わせ

Inquiry Information

製品名:
Nrf2 activator-24
製品番号:
HY-182040
数量:
MCE 日本正規代理店: